Connect with us

Opinion

Brazil: The vanguard of the delay in medical cannabis

Published

em

Listen to this article
Reading Time: 2 minutes

On 14/10/2022, the Federal Council of Medicine of Brazil (CFM) published Resolution 2.324/2022, on the therapeutic use of Cannabis, updating Resolution 2.113/2014 on the same topic, and amended the current regulations on the use of cannabis. medical prescription, maintaining restrictions on some clinical conditions subject to the therapeutic use of Cannabis.

Resolutions nº 2113 of 2014 (revoked) and nº 2324 of 2022 (in force), deal with the use of cannabidiol (CBD) for the treatment of “childhood and adolescent epilepsy refractory to conventional therapies” and prohibit the doctor from prescribing cannabis. in natura for medicinal use, as well as any derivatives other than CBD.

The new resolution, different from the previous one, (i) specifies and restricts which clinical conditions can be treated with CBD, namely: epilepsies treatable with Cannabidiol, citing the three applicable cases: Dravet and Lennox-Gastaut syndrome, in addition to of the Tuberous Sclerosis Complex.

It also (ii) ceases to restrict the prescription only to the specialties of neurology, neurosurgery and psychiatry and (iii) prohibits physicians from giving lectures and courses on the use of cannabidiol and/or products derived from Cannabis outside the scientific environment, as well as from advertising disclosure.

With this positioning, CFM continues to impose on Brazil its position in the vanguard of the backwardness regarding the medicinal use of Cannabis. Arbitrarily restricting the role of medical professionals both in clinical practice and in the dissemination of information on the medical uses of cannabis derivatives. The risk is that this new norm is a door to the persecution of doctors who treat their patients with Cannabis, as has already been done with some doctors in Brazil”, he says.

An unconstitutional resolution
The Resolution of the Federal Council of Medicine is totally unconstitutional, since it directly affects the dignity of the human person and the right to health, when it threatens and aims to stop treatments with Cannabis, which are already taking place and effectively to relieve pain and or symptoms of patients in Brazil, for arbitrary reasons, without plausible medical-scientific justifications.

In the opinion of lawyer Ricardo Nemer, also a member of Rede Reforma “this is a scientific and legal terraplanism, worse than offending human dignity and the right to health, as there is still the practice of a crime. CFM is committing a crime of failure to provide assistance, Article 135 of the Brazilian Penal Code – Failing to provide assistance, when possible without personal risk, to an abandoned or lost child, or to an invalid or injured person, who is helpless or in serious and imminent danger; or not to ask, in these cases, the relief of public authority: Penalty – detention, from one to six months, or fine.”

There is no way to dismiss, deny or make invisible the political moment in which Brazil finds itself and lives, close to an election that will decide whether or not to re-elect the current president, Bolsonaro, a character declared to be linked to neo-Petencostal religious precepts and against Cannabis in any case. aspects. The other candidate, in turn, Lula da Silva, who is less conservative and more leftist, may be a hope for a change in the direction of the matter in the country.

Until then, it is time to be very cautious and wait, with wishes for a better future for patients who make therapeutic use of Cannabis in Brazil.
____________________________________________________________

*Emilio Figueiredo is a lawyer in Brazil, works primarily with cannabis and is a member of Rede Reforma.
** Aquiles Castro Junior is a lawyer in Brazil and Portugal and a member of the Scientific Council of the Mothers for Cannabis Movement in Portugal

The authors write in Brazilian Portuguese.

 

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

Aquiles Castro
Lawyer |  More posts
Emilio Figueiredo
Advertise with us!
Support independent journalism about cannabis.
Cannareporter needs you to continue informing.
If our work helps you stay up-to-date on cannabis policy, science, and industry, please consider supporting us with a monthly contribution on Patreon. Every contribution counts to keep the project free and independent.
Support us on Patreon
You can cancel your support at any time. Thank you for being part of our community.
Comment
Subscribe
Notify of

1 Comment
Inline feedback
View all comments
3 years ago

It is incredible how some governments out of ignorance block the development of this therapeutic option of medical cannabis for doctors and patients, we will continue working, greetings from Colombia

Advertise with us!


Watch the Documentary "Patients" by Laura Ramos

Documentary Patients Laura Ramos help us grow

Mais recentes

International1 hours ago

Bedrocan supplies cannabis flowers with 25% THC to the German market.

Reading Time: 2 minutes. Bedrocan has just released a version of its 'Bedrocan' cannabis flowers with 25% THC....

Analysis2 days ago

A report by ICAD reveals that daily cannabis consumption among young people in Portugal is less than 1%.

Reading Time: 6 minutes The Institute for Addictive Behaviors and Dependencies (ICAD) published on December 2nd...

Business2 days ago

Cannabis has already generated more than $5,4 billion in tax revenue for Canada since 2018.

Reading Time: 3 minutes. Canada has already collected more than 5,4 billion Canadian dollars in tax revenue since...

Press Releases2 days ago

GrowerIQ renews its Good Manufacturing Practices (GMP) compliance through independent validation by RQC.

Reading Time: 2 minutes Toronto, Canada – December 2 – GrowerIQ, a global leader in compliance and tracking software...

International3 days ago

Peter Homberg, a renowned German lawyer specializing in cannabis and life sciences, has died.

Reading Time: 5 minutes. The legal and cannabis industry community was surprised this Friday, December 5th, with...

Analysis5 days ago

Iberia Faces Strategic Headwinds as Europe’s Prime Cannabis Industrial Hub

Reading Time: 7 minutes For five years, the European cannabis industry has been looking to the Iberian Peninsula for...

Science6 days ago

Beatriz Emygdio: "Brazil has the potential to be a global leader in the cannabis sector."

Reading Time: 5 minutes. The Brazilian Agricultural Research Corporation (Embrapa) has been officially authorized by the National Health Surveillance Agency (ANVISA)...

Science1 weeks ago

Cannabinoids offer new hope fighting against cervical cancer.

Reading Time: 3 minutes A scientific review of preclinical studies recently published in the Journal of Cancer Research and Clinical Oncology points to...

ADVERTISING1 weeks ago

EU-certified medical vaporizers enter the market: setting a new regulatory standard.

Reading Time: 3 minutes. The race for relevance in the global cannabis community has taken a new turn with the introduction of...

Science1 weeks ago

USA: Clinical trial recreates real-life experience and reiterates that cannabis use reduces alcohol consumption.

Reading Time: 3 minutes A clinical trial conducted by a team of researchers at Brown University in the USA, published in...